Purchase Order 75N95023P00857

Award Date 9/19/23
Potential Completion Date 9/18/24
Potential Value $25K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, has been awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to provide services leveraging electronic health records. The contract has a period of performance of just under one year, running from September 2023 through September 2024. Work will be conducted in Baltimore,...
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, has been awarded a firm fixed price purchase order valued at $19,827.67 by the National Institutes of Health's National Institute on Drug Abuse. The contract is for Kaiser Permanente to finalize project objectives and scope for a patient cohort study, including eligibility criteria and intended outcomes. Performance will take place in Baltimore, Maryland over a one year period from...
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, was awarded a $24,999 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Office of Logistics and Acquisition Operations. To be performed in Rockville, Maryland through August 2024, this contract has no set-aside designation and is likely to facilitate research support services aligned with Kaiser Permanente's capabilities and...
This is a $15,000 firm fixed price purchase order awarded by the National Cancer Institute (NCI) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente. The contract is for data services to support the NCI's research initiatives. Kaiser Permanente's Kaiser Foundation Research Institute division, a non-profit healthcare provider and research organization, will be performing the work. The contract has no set-aside designation, reflecting Kaiser Permanente's status as a large,...
This federal contract award, worth $8,834,540.78, was issued by the National Institute on Drug Abuse (NIDA) to the prime contractor Kaiser Foundation Health Plan Of Washington, a non-profit healthcare organization. The contract does not have a set-aside designation. The contract supports vaccine safety surveillance, research and development, and vaccine treatment and evaluation services. Kaiser Foundation Health Plan Of Washington has previously provided similar services to other federal...
The National Institute on Drug Abuse, a component of the Department of Health and Human Services' National Institutes of Health, awarded a firm fixed-price purchase order valued at $25,000 to Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, operating as Kaiser Permanente. The objective of this contract is to investigate Glucagon-Like Peptide-1 (GLP-1) analogues as a novel pharmacotherapeutic approach for Alcohol Use Disorder (AUD). Work will be performed in Baltimore,...
Kaiser Foundation Hospitals, doing business as Kaiser Permanente, was awarded a definitive cost-no-fee contract by the Department of Health and Human Services Food and Drug Administration (FDA) on September 26, 2018. The contract has a potential value of $5,646,115.20 and completion date of February 28, 2023. It concerns research on the effects of medical products on suicidal ideation and behavior through real world evidence, as initially solicited in a February 13, 2018 Broad Agency...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $149,993 firm fixed-price purchase order to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract is for the retrieval and tracking of breast tissue sample blocks to support studies of the risk of new malignancies following breast cancer. This contract is not set aside for any specific business category. Kaiser...
This federal contract award is for $636,976.25 and was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a nonprofit healthcare provider and research organization. The contract is for infrastructure setup and is a delivery order under the larger "Cancer Study Cohort Recruitment" indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $113,163 firm-fixed-price purchase order to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, to procure a limited data set focused on specific racial and ethnic subgroups for predicting patterns of nontuberculous mycobacterial pulmonary disease. This sole-source award is based on Kaiser Permanente's unique capability to provide the required...

Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, has been awarded a $25,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for Kaiser Permanente to leverage electronic health records data to support NIDA's biomedical and behavioral research programs. Performance will take place in Baltimore, Maryland over a one year period ending in September 2024. No subcontractors or set aside designations were indicated. This contract enables NIDA to utilize Kaiser Permanente's extensive clinical data for research aimed at improving prevention and treatment of substance use disorders.

Generated 12/15/23, 9:50 PM